Ajooni Biotech Ltd

Ajooni Biotech Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Ajooni Biotech Ltd

₹ 5.07 -1.55%
17 Nov 11:59 a.m.
ajoonibiotech.com NSE: AJOONI
About

Incorporated in 2010, Ajooni Biotech Ltd is a PURE VEG. animal health care solutions company. It is a significant player in the animal feed and aquaculture sectors.[1]

Key Points

Business Overview:[1]
ABL was incorporated in February 2010 and was promoted by Mr Jasjot Singh (chairman and managing director). It manufactures a variety of compound animal feed such as cattle feed, cattle feed chips, camel feed, cotton oil cake, mustard oil cake and a wide range of feed supplements. Facilities in Khanna, Punjab, have a total installed capacity of 60,000 MTPA.

Website NSE
  • Market Cap ₹ 87.3 Cr.
  • Current Price ₹ 5.07
  • High / Low ₹ 8.55 / 4.80
  • Stock P/E 21.9
  • Book Value ₹ 5.21
  • Dividend Yield 0.00 %
  • ROCE 6.91 %
  • ROE 5.15 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Stock is trading at 0.96 times its book value
  • Company is expected to give good quarter
  • Debtor days have improved from 70.5 to 51.7 days.

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding is low: 26.9%
  • Company has a low return on equity of 4.87% over last 3 years.
  • Earnings include an other income of Rs.2.53 Cr.
  • Promoter holding has decreased over last 3 years: -5.52%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Fast Moving Consumer Goods Fast Moving Consumer Goods Food Products Animal Feed

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
10.29 10.63 41.26 21.00 19.48 20.05 19.58 25.66 25.72 34.03 29.27 31.27 31.74
9.70 10.15 40.32 20.34 18.85 20.70 17.99 24.70 24.95 33.10 28.26 30.56 30.24
Operating Profit 0.59 0.48 0.94 0.66 0.63 -0.65 1.59 0.96 0.77 0.93 1.01 0.71 1.50
OPM % 5.73% 4.52% 2.28% 3.14% 3.23% -3.24% 8.12% 3.74% 2.99% 2.73% 3.45% 2.27% 4.73%
0.00 0.02 0.26 0.07 0.29 1.57 0.26 0.04 0.31 0.39 1.34 0.65 0.15
Interest 0.13 0.13 0.12 0.13 0.19 0.12 0.11 0.15 0.06 0.07 0.06 0.08 0.17
Depreciation 0.25 0.26 0.24 0.21 0.21 0.21 0.24 0.22 0.23 0.24 0.38 0.25 0.25
Profit before tax 0.21 0.11 0.84 0.39 0.52 0.59 1.50 0.63 0.79 1.01 1.91 1.03 1.23
Tax % 19.05% 0.00% 35.71% -2.56% 23.08% 23.73% 38.67% 25.40% 22.78% 27.72% 19.37% 24.27% 24.39%
0.16 0.11 0.54 0.40 0.40 0.44 0.91 0.47 0.62 0.73 1.54 0.78 0.93
EPS in Rs 0.01 0.01 0.03 0.02 0.02 0.03 0.05 0.03 0.04 0.04 0.09 0.05 0.05
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
1 7 13 29 42 40 40 51 74 74 80 115 126
1 7 13 28 41 39 39 49 71 72 78 111 122
Operating Profit 0 0 0 1 1 1 1 2 3 3 2 4 4
OPM % 2% 2% 2% 2% 2% 2% 3% 3% 4% 4% 3% 3% 3%
0 0 0 0 0 0 0 0 0 0 2 2 3
Interest 0 0 0 0 0 0 0 1 1 0 1 0 0
Depreciation 0 0 0 0 0 0 0 1 1 1 1 1 1
Profit before tax 0 0 0 0 0 0 0 0 1 2 3 4 5
Tax % 0% 27% 29% 28% 20% 15% 29% 26% 28% 28% 28% 22%
0 0 0 0 0 0 0 0 1 1 2 3 4
EPS in Rs 0.02 0.12 0.18 0.36 0.03 0.03 0.02 0.02 0.05 0.06 0.12 0.20 0.23
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 32%
5 Years: 23%
3 Years: 16%
TTM: 39%
Compounded Profit Growth
10 Years: 47%
5 Years: 56%
3 Years: 47%
TTM: 63%
Stock Price CAGR
10 Years: %
5 Years: -6%
3 Years: -17%
1 Year: -31%
Return on Equity
10 Years: 5%
5 Years: 5%
3 Years: 5%
Last Year: 5%

Balance Sheet

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 0.24 0.24 0.24 0.33 6 6 8 10 10 18 18 34 34
Reserves 0 0 0 1 5 6 7 6 6 24 25 54 55
0 0 1 1 5 5 5 7 5 5 2 2 9
0 1 1 11 4 1 2 6 7 12 3 5 5
Total Liabilities 0 2 2 13 19 18 23 28 29 59 48 95 104
0 0 0 1 1 1 2 5 6 6 10 11 11
CWIP 0 0 0 0 0 0 0 0 0 0 1 0 11
Investments 0 0 0 6 6 4 3 1 1 4 2 3 3
0 1 2 6 12 13 18 22 22 48 34 80 78
Total Assets 0 2 2 13 19 18 23 28 29 59 48 95 104

Cash Flows

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
0 -1 -3 -3 -5 -4 1 4 -6 23 -18
-0 -0 -2 -0 1 0 -3 -2 -16 8 -17
0 1 5 8 -1 3 2 -2 22 -4 25
Net Cash Flow 0 -0 0 5 -5 -1 0 -0 0 27 -10

Ratios

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 58 40 33 17 25 44 115 98 68 101 59 52
Inventory Days 141 22 14 63 19 51 34 46 34 39 80 90
Days Payable 100 66 27 79 9 12 20 46 39 56 8 13
Cash Conversion Cycle 99 -4 20 1 35 84 129 98 63 83 131 129
Working Capital Days 96 5 9 -29 -1 84 105 77 58 94 132 160
ROCE % 28% 18% 37% 10% 4% 4% 5% 9% 6% 8% 7%

Shareholding Pattern

Numbers in percentages

Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
36.39% 36.39% 30.28% 27.46% 26.44% 26.44% 26.89% 26.89% 26.89% 26.89% 26.89% 26.89%
0.01% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.29% 0.18% 0.00% 0.00% 0.00%
63.60% 63.59% 69.72% 72.53% 73.56% 73.56% 73.11% 72.82% 72.92% 73.11% 73.11% 73.11%
No. of Shareholders 16,42921,18721,54822,95030,93341,05351,22463,90664,10263,96863,30564,305

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Right Issue

Credit ratings

Concalls

  • Jan 2025
    Transcript
    Notes
    PPT
  • Oct 2024
    Transcript
    Notes
    PPT
  • May 2024
    Transcript
    Notes
    PPT
  • May 2024
    Transcript
    Notes
    PPT
  • Jun 2022
    Transcript
    Notes
    PPT
  • Feb 2021
    Transcript
    Notes
    PPT